ACUTA CAPITAL PARTNERS, LLC Hedge Fund

CIK: 0001582844 · Show all filings

Period: Q4 2019 (← Previous) (Next →)

Filing Date: Feb 14, 2020

Total Value ($000): $403,795 (100.0% shares, 0.0% debt)

Holdings (38)

AXSM AXSOME THERAPEUTICS INC 15.6%
Value ($000) $62,791 Shares 607,500 Est. Cost $23.68 Unrealized +70.6%
XBI SPDR SERIES TRUST 11.8%
Value ($000) $47,555 Shares 500,000 Est. Cost Unrealized
ARWR ARROWHEAD PHARMACEUTICALS IN 7.0%
Value ($000) $28,068 Shares 442,500 Est. Cost $23.72 Unrealized +109.2%
KADMON HLDGS INC 6.8%
Value ($000) $27,361 Shares 6,040,000 Est. Cost $3.68 Unrealized
AUPH AURINIA PHARMACEUTICALS INC 5.3%
Value ($000) $21,425 Shares 1,057,500 Est. Cost $6.93 Unrealized +32.9%
INTRA CELLULAR THERAPIES INC 5.0%
Value ($000) $20,143 Shares 587,089 Est. Cost $34.31 Unrealized
IOVA IOVANCE BIOTHERAPEUTICS INC 4.5%
Value ($000) $18,172 Shares 656,500 Est. Cost $7.92 Unrealized +187.3%
ADVERUM BIOTECHNOLOGIES INC 3.8%
Value ($000) $15,235 Shares 1,322,500 Est. Cost $11.52 Unrealized
ARVN ARVINAS INC 3.6%
Value ($000) $14,628 Shares 356,000 Est. Cost $19.30 Unrealized +51.7%
AVADEL PHARMACEUTICALS PLC 3.0%
Value ($000) $12,269 Shares 1,625,000 Est. Cost $7.55 Unrealized
XENE XENON PHARMACEUTICALS INC 3.0%
Value ($000) $12,028 Shares 917,500 Est. Cost $8.16 Unrealized +29.0%
KARYOPHARM THERAPEUTICS INC 2.8%
Value ($000) $11,310 Shares 590,000 Est. Cost $15.33 Unrealized
BCRX BIOCRYST PHARMACEUTICALS 2.4%
Value ($000) $9,746 Shares 2,825,000 Est. Cost $2.52 Unrealized 0.0%
CONSTELLATION PHARMCETICLS I 2.3%
Value ($000) $9,304 Shares 197,500 Est. Cost $47.11 Unrealized
DICERNA PHARMACEUTICALS INC 2.1%
Value ($000) $8,537 Shares 387,500 Est. Cost $22.03 Unrealized
MIST MILESTONE PHARMACEUTICALS IN 2.0%
Value ($000) $8,141 Shares 508,500 Est. Cost $19.80 Unrealized -10.3%
IVERIC BIO INC 1.9%
Value ($000) $7,808 Shares 910,000 Est. Cost $8.58 Unrealized
REATA PHARMACEUTICALS INC 1.9%
Value ($000) $7,768 Shares 38,000 Est. Cost $80.29 Unrealized
BELLUS HEALTH INC NEW 1.5%
Value ($000) $6,156 Shares 810,000 Est. Cost $6.43 Unrealized
APLS APELLIS PHARMACEUTICALS INC 1.4%
Value ($000) $5,741 Shares 187,500 Est. Cost $27.68 Unrealized 0.0%
SELECTA BIOSCIENCES INC 1.3%
Value ($000) $5,345 Shares 2,364,204 Est. Cost $2.26 Unrealized
NEOLEUKIN THERAPEUTICS INC 1.1%
Value ($000) $4,589 Shares 372,500 Est. Cost $12.32 Unrealized
KARUNA THERAPEUTICS INC 1.0%
Value ($000) $4,219 Shares 56,000 Est. Cost $75.34 Unrealized
APPLIED THERAPEUTICS INC 1.0%
Value ($000) $4,037 Shares 148,000 Est. Cost $18.14 Unrealized
INSM INSMED INC 1.0%
Value ($000) $4,036 Shares 169,000 Est. Cost $26.21 Unrealized -22.4%
INTRA CELLULAR THERAPIES INC 0.8%
Value ($000) $3,431 Shares 100,000 Est. Cost $34.31 Unrealized
KURA KURA ONCOLOGY INC 0.8%
Value ($000) $3,300 Shares 240,000 Est. Cost $16.00 Unrealized -7.4%
ZYMEWORKS INC 0.8%
Value ($000) $3,205 Shares 70,500 Est. Cost $30.08 Unrealized
IMMUNOMEDICS INC 0.8%
Value ($000) $3,174 Shares 150,000 Est. Cost $21.16 Unrealized
ASND ASCENDIS PHARMA A S 0.8%
Value ($000) $3,130 Shares 22,500 Est. Cost $139.11 Unrealized
KALV KALVISTA PHARMACEUTICALS INC 0.5%
Value ($000) $1,915 Shares 107,500 Est. Cost $13.85 Unrealized -5.8%
MEDICINES CO 0.5%
Value ($000) $1,843 Shares 21,700 Est. Cost $84.93 Unrealized
QURE UNIQURE NV 0.4%
Value ($000) $1,792 Shares 25,000 Est. Cost $54.91 Unrealized 0.0%
ACASTI PHARMA INC 0.4%
Value ($000) $1,519 Shares 620,000 Est. Cost $2.45 Unrealized
CHEMOCENTRYX INC 0.3%
Value ($000) $1,384 Shares 35,000 Est. Cost $39.54 Unrealized
ADVERUM BIOTECHNOLOGIES INC 0.3%
Value ($000) $1,152 Shares 100,000 Est. Cost $11.52 Unrealized
ZAFGEN INC 0.3%
Value ($000) $1,110 Shares 1,000,000 Est. Cost $1.11 Unrealized
X4 PHARMACEUTICALS INC 0.1%
Value ($000) $428 Shares 40,000 Est. Cost $10.70 Unrealized